For the latest COVID-19 Travel restrictions and recommendations please click here

SMi Group’s 21st  annual European Pharmaceutical Pricing and  Reimbursement  conference returns to London this October. 
 It will be held on the 5th to the 6th October 2015 at the Holiday Inn Hotel Regents Park, London. The conference is one of the most established in the world having run for 21 years highlighting the changes in the field over this period of time.  


This year’s agenda will have a strong focus on international changes in policy along with an in-depth section on biosimilar drugs and the impact they have had on Pricing and Reimbursement through different nations in Europe.

Key topics include:

New models for cancer drug funding

Developing new market access models for orphan drugs

Changes in the PPRS scheme post election

Tiered pricing

• Gain key insights into the field of biosimilar drugs
• The impact of biosimilar in the field of pricing and reimbursement
• Learn about new policies
• Gain invaluable information from field leaders through in depth case studies
• Gain a strong understanding of current and potential changes in HTA
• Developing co-creation relations with payers and stakeholders.
• Using new Payment models
• Health reforms and harmonisation in Europe


Adelphi Values; Astellas Pharma Europe; Biopharm Insight; Bristows LLP; DM Pharma Issues Ltd; Ethical Medicines Industry Group; EUCOPE; Forest Laboratories Inc.; Future for Health Ltd; GBI Health; GlaxoSmithKline; H. Lundbeck A/S; IGES Institut.; IMS Health UK; Ipsen; Janssen Strategic Marketing; Janssen-Cilag Germany; Model N UK Ltd.; Model N, Inc.; Mundipharma; Mundipharma International; National Healthcare Institute; Ox Thera AB; Quintiles (UK) Ltd; Recordati Industria Chimica E Farmaceutica S P A; SOTIO a.s.; The Economist Group; The Health Access Agency; The National Pharmaceutical Association Ltd; Thomson Reuters; Tillotts Pharma AG; Two Scenarios; UCB; University of Ferrara;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Leslie Galloway

Leslie Galloway, Chairman, Ethical Medicines Industry Group

9:10 The Future for Innovation

Leslie Galloway

Leslie Galloway, Chairman, Ethical Medicines Industry Group

• The challenges for Assessors and Payers
• Expectations of Industry
• Adoption and Diffusion

9:45 New Models for European Reimbursement: Developing the Best Socioeconomic Outcome

Nick Bosanquet

Nick Bosanquet, Professor of Health Policy, Imperial College London

• Issues with current reimbursement models
• Describing various new models of physician payment that can serve as a foundation for a shift away from the current reimbursement system for cancer care to support better outcomes and avoid preventable costs
• Developing Physician incentives to provide the best care for the patient.
• Value based pricing


10:20 Morning Coffee

10:50 IQWiG or even the G-BA in a Dilemma? The Oncology Guidelines in Contradiction to Patient Preferences in Germany

Stefan Walzer

Stefan Walzer, General Manager (MArS) – Tutor , MArS Market Access & Pricing Strategy GmbH and State University Baden-Wuerttemberg

• AMNOG process and the role of IQWiG
• Key findings of the IQWiG oncology guideline
• Comparison of the IQWiG guideline recommendations with available oncology reviews
• Discussion of potential contradictions
• Introduction of a new focus: Patient preferences
• Discussion of the impact of patient preferences on the oncology guideline and future assessments
• Conclusions

11:25 The Commercial Environment in the UK

Jaime Edwards

Jaime Edwards, Commercial Manager, Astellas Pharma Europe Ltd

12:00 The Affordability Conundrum – Patients and Patient Groups as Honest Brokers

Eric Low

Eric Low, CEO, Myeloma UK

12:35 Lunch

13:35 New Models for Cancer Drug Funding

Steve  Williamson

Steve Williamson, Consultant Cancer Pharmacist, Northumbria NHS Trusts / NHS England


•  Cutting funding of current drugs
•  Making room in the market for novel drugs
•  Understanding the impact of the cancer drug fund on cancer treatment strategies


14:10 German Pricing and Reimbursement

Cord Willhoft

Cord Willhoft, Partner, Field Fisher

• Discover how to access the German Pharmaceutical market

• Clarifying reimbursement authorities

•  Problems with the current framework


15:20 Afternoon Tea

15:50 The Impact of Biosimilars on the Market

Alexander  Roediger

Alexander Roediger, Director EU Affairs, MSD Europe, Inc. on behalf of EBE/EFPIA, MSD

• Analysing the characteristics of biosimilars and the

development of the EU’s biosimilars market

• Exploring the likely impact of biosimilars on future

pharmaceutical budgets based on different scenarios and


• Identifying opportunities and challenges for industry,

patients and payers, as well as appropriate pricing and

reimbursement options

16:25 Biosimilars- an NHS perspective

Maggie  Dolan

Maggie Dolan , Specialist Procurement Pharmacist, NHS Commercial Solutions



 •             What are the barriers to uptake
•             How can these barriers be managed
•             Contracting strategies for biosimilars
•             Lessons learnt for the future




17:00 Roundtable: Does the PPRS work for Patients and Innovation

Leslie Galloway

Leslie Galloway, Chairman, Ethical Medicines Industry Group


• How is the current PPRS working?
• What are the benefits to patients?
• What are the benefits to the NHS
• What is the impact on innovation?

17:35 Chairman's Closing Remarks and Close of Day One

Leslie Galloway

Leslie Galloway, Chairman, Ethical Medicines Industry Group

8:30 Registration & Coffee

8:50 Chairman's Opening Remarks

Alexander Natz

Alexander Natz, Secretary General, EUCOPE – European Confederation of Pharmaceutical Entrepreneurs

9:00 Changes in the PPRS Scheme to Enhance both the Health and Wealth of the UK

David Watson

David Watson, Director of Pricing & Reimbursement, Association of the British Pharmaceutical Industry (ABPI)

• Ensuring the future availability of new and improved medicines in this and other countries
• Developments in the PPRS scheme and NICE
• Future developments under the PPRS scheme.

9:35 Flexible Pricing Mechanisms. Are the European Systems Ready for Them?

Peter Hertzman

Peter Hertzman, CEO, Health Access Agency

• Understanding requirements
• New pricing flexible pricing and contracting schemes
• Providing value for external stakeholders

10:10 Morning Coffee

10:35 Tiered Pricing

Ken Walsh

Ken Walsh, Head of Pricing, Emerging Markets , GlaxoSmithKline

• Increasing market access through the development of Tiered pricing
• Understanding new mechanisms to accessing a challenging market
• Developing socioeconomic methodologies to increase medication access 

11:10 Extended Session: HTA Uncovered




• Drivers of success and failure

• What they don’t print in the rules

• Understanding the HTA map: Key agencies

• Types of assessment and evaluation

• Differences and similarities

Janice Haigh

Janice Haigh, Practice Leader, Market Access, Quintiles (UK) Ltd

Anke van Engen

Anke van Engen, Principal, Advisory Services, Quintiles

12:40 Lunch

13:40 Orphan Medicinal Products and National Challenges: Are HTA Procedures Fit for Purpose?

Alexander Natz

Alexander Natz, Secretary General, EUCOPE – European Confederation of Pharmaceutical Entrepreneurs

• How are OMPs currently assessed in national HTAs?
• Why is there a need for a specific HTA assessment?
• What could a suitable HTA for orphan medicines look like?

14:15 Coordination of HTA between EU Member States: Current Pilots and Political Initiatives

Alexander Natz

Alexander Natz, Secretary General, EUCOPE – European Confederation of Pharmaceutical Entrepreneurs

• Development of further harmonisation of systems in the EU
• Pros and cons of multiple country mechanisms.
• Providing opportunities to slow or stop disease progression

14:50 ROUNDTABLE: Trends and Drivers - Game Changers for P&R

Matthias Heck

Matthias Heck, Attorney-at-law, Head of Brussels office, German Pharmaceutical Industry Association



• Discovering the role of EMA / national competent

authorities in a changing P&R landscape.

• Understanding specific challenges for specialized markets

(orphan drugs / biosimilars).

• Transparency rules – boone or bane?


15:20 Afternoon Tea

15:45 Latest on Drug Pricing in Japan

Donald Macarthur

Donald Macarthur, Global Pharmaceutical Business Analyst, DM pharma issues

• Likely 2016 pricing reforms
• Will there be new pharmacoeconomic demands?  
• Application of new points-based system to forecast price premiums
• Prospects for an exceptional price revision in 2017

16:20 Market Access in Turkey: Risks and Opportunities in the Post Healthcare Transformation Era

Toros Sahin

Toros Sahin, Head of Market Access & Health Economics, Sanofi-Turkey

• Overview of Turkish Market Access & Healthcare Environment
• Basics of the Turkish Pricing & Reimbursement System
• Changing dynamics of the reimbursement system: Alternative models
• Government’s mid-long term vision on pharmaceutical industry

16:55 New Models for Reimbursement, Developing the Best Socioeconomic Outcome: An Italian Perspective

Fabrizio Gianfrate

Fabrizio Gianfrate, Professor of Health Economics, University of Rome

17:30 Chairman's Closing Remarks and Close of Day Two

Alexander Natz

Alexander Natz, Secretary General, EUCOPE – European Confederation of Pharmaceutical Entrepreneurs


Sponsors and Exhibitors


European Pharmaceutical Pricing & Reimbursement Interview with Myeloma UK


Attendee List for European Pharmaceutical Pricing & Reimbursement 2015


European Pharmaceutical Pricing & Reimbursement Interview with EMIG


European Pharmaceutical Pricing & Reimbursement Interview with GSK


Sponsors and Exhibitors


Sponsors and Exhibitors

Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. We are positioned at the intersection of business services and healthcare, conduct business in approximately 100 countries and have more than 32,000 employees. We use the breadth and depth of our service offerings, our global footprint and our therapeutic, scientific and analytics expertise to help our biopharmaceutical customers, as well as other healthcare customers, navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.

Media Partners



Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.



MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com

Contract Biotechnology


Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.



LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.

International Journal of Bioinformatics Research and Applications


Bioinformatics is an interdisciplinary research field that combines biology, computer science, mathematics and statistics into a broad-based field that will have profound impacts on all fields of biology. The emphasis of IJBRA is on basic bioinformatics research methods, tool development, performance evaluation and their applications in biology. IJBRA addresses the most innovative developments, research issues and solutions in bioinformatics and computational biology and their applications.

Thomson Reuters


Thomson Reuters is the leading source of intelligent information for professionals around the world. We provide essential information to keep you in touch with the rapidly-changing pharmaceutical and chemical markets, expert services to help you make informed, early decisions, and intuitive technology to manage and support your discovery and development activities. Our products give you the intelligence, tools and expertise to help you optimize your IP portfolio, monitor industry developments, identify licensing and partnering opportunities, deliver successful regulatory submissions, and support your scientific messaging, marketing, product positioning, and awareness campaigns.

International Journal of Behavioural and Healthcare Research


IJBHR addresses a broad range of original experimental and theoretical papers that deal with behavioural and healthcare concerns. It welcomes high-quality papers from scientists in academic and non-academic organisations as well as business and government worldwide. IJBHR is sponsored by the Business and Economics Society International and the Frontiers in Immunology Research Network.

International Journal of Biotechnology


IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.

KONGPOSH Publications


KONGPOSH Publications is one of India’s leading Pharma Publishers. The Pharma Review® is a bi-monthly article based journal covering various fields of pharmacy. Participation and distribution in over 30 Expos & Conferences worldwide each year. It is widely read by decision makers, middle management and the academia. Also available in E-book format. Other publications : Indian Pharma Reference Guide (Annual) – Names and address of Pharmaceuticals, Bulk Drugs, Machinery’s & Instrumentation, AYUSH Manufacturers; and much more; High Performance Thin Layer Chromatography; Elements of Pharmacovigilance; Regulation of Clinical Trials; AYUSH (CD); NDDS/AMD (CD)



Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.



FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!

The Pharma Letter


The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.



Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.

Pharmaceutical Technology


Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.



Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!

Antibodies Online


antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.



CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.



Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.

The Pharma Letter


The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.

American Pharmaceutical Review


Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy





A pioneer in the field, HealthEconomics.Com is the world’s most comprehensive and credible website for resources and jobs in healthcare value and market access. A trusted resource, HealthEconomics.Com contains the hottest news, jobs, policy updates, professional development, and education resources, and offers unparalleled advertising opportunities. As the #1 Google ranked website in health economics, HealthEconomics.Com attracts 11,000 visitors every month and the well-respected Newsletter reaches 20,000 professionals every week. The comprehensive content is carefully selected by a discerning health economist editor, making us the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

Technology Networks


Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com

Drug Development Technology


Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.

Pharmaceutical Outsourcing


Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.

Medical News Today


Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.



PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….



PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.



PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.

International Journal of Medical Engineering and Informatics


IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.



GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.

Swiss Biotech Association


The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.

Sociable Pharma


Sociable Pharma offers a tailored range of research & analysis services to help pharmaceutical companies at all stages of the product lifecycle. We provide customized research & analysis solutions that address the evolving intelligence priorities of each marketed and pipeline product to deliver commercially-focused & highly relevant insight. Our Treatment Pulse business intelligence service helps pharmaceutical companies to understand physicians' perspectives on clinical practice, unmet needs and product differentiation, and continuous primary research analyzes the impact that industry issues will have on the treatment landscape and the implications for each product's competitive positioning.

Pharma Marketing News


Pharma Marketing News is an independent monthly electronic newsletter focused on issues of importance to pharmaceutical marketing executives. It is a service of the Pharma Marketing Network -- The First Forum for Pharmaceutical Marketing Experts -- which brings together pharmaceutical marketing professionals from manufacturers, communications companies, and marketing service providers for wide ranging discussions and education on a multitude of current topics. Pharma Marketing Network & Pharma Marketing News provide executive-level content coupled with permission-based e-marketing opportunities.



Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/



Biotechgate is a global, comprehensive, life science database covering the Biotech, Pharma and Medtech industries. There are currently over 38,000 company profiles on the Biotechgate database. Biotechgate is commonly used to find product pipelines, collaboration partners, in/out-licensing opportunities and information about technology platforms, management details, new business leads and financing rounds. In addition, our licensing deals database supports companies in negotiating their licensing agreements.

Bentham Science


Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here

Select Science


SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.



pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com

British Pharmacological Society


The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.

International Pharmaceutical Industry


IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.

Holiday Inn Regents Park

Carburton Street
London W1W 5EE
United Kingdom

Holiday Inn Regents Park

Choose the well-connected Holiday Inn London-Regent's Park hotel, with a superb central London location and speedy transport links. Holiday Inn London-Regent's Park is in a leafy and cosmopolitan area of central London, a 10-minute walk from bustling Oxford Street. Leave your car in our NCP managed underground car park, and explore London by Tube. Great Portland Street Tube station is 25 metres from the hotel, from where you can reach the City and Canary Wharf in 30 minutes, and London Heathrow Airport in 45 minutes.

Wireless Internet is available throughout the hotel, and you can invite up to 300 people to events at the Academy Conference Centre, with an IT technician and break-out zones. Holiday Inn London-Regent's Park is a 10-minute walk from Santander's offices and businesses in the BT Tower. Stroll 5 minutes to Regent's Park, where you'll find London Zoo and pretty Primrose Hill. We're a 10-minute walk from Bond Street boutiques and 20 minutes from Buckingham Palace and cruises on the River Thames.

Ask our Concierge to plan your day out and book West End theatre tickets. Room Service is available 24 hours at Holiday Inn London-Regent's Park, or dine in the vibrant Junction Restaurant. Our Junction Bar has a menu of light bites, and a hot breakfast buffet is served daily.



speaker image






CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title


Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event


Sign up
Forgotten Password?


UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71

Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SMi.
Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out